Zortix
Today
Ideas
Tickers
Podcasts
Following
Sign in
Everything said about
QTTB
+ Watchlist
0
Ideas · 30d
1
Episodes
4.0
Avg depth
1
Ideas · all time
The conversation · most recent first
10 JUN
10 JUN
YET ANOTHER VALUE PODCAST · 07:15
Nectar Therapeutics sell-off seen as overdone
"The guest argued that Nectar's recent stock decline is an overreaction to transient headwinds like litigation and perceived competition, leaving the underlying asset undervalued."
MIXED
In depth · 4/5
MENTIONS & DEPTH REFLECT PODCAST DISCUSSION VOLUME · NOT A RATING, FORECAST, OR RECOMMENDATION